GTR 120024758
Tenders Are Invited For Delivery Of Medicinal Products For Drug Programs, Immunoglobulins And Infusion Fluids For Patients Of The Specialist Hospital In Zabrze Sp. Z O. O.; Case No. Dzp/18 Tp/2026.
ICB — International Competitive Bid
Closes Nov 09, 2026
— 7 days left
central europe
Tender Information
GTR Reference
120024758
Tendering Authority
Subscribe to view
Tender No
DZP/18 TP/2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Delivery Of Medicinal Products For Drug Programs, Immunoglobulins And Infusion Fluids For Patients Of The Specialist Hospital In Zabrze Sp. Z O. O.; Case No. Dzp/18 Tp/2026.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
central europe
Political Region
European Union
Last Date of Bid Submission
09-11-2026
7 days left
Work Detail
Package No. 1 Bimekizumab B 161. A Detailed Description Of The Subject Of The Order Is Attached As Annex No. 3 To The Swz - Assortment And Price Form.3.Conditions Required From Contractors - Contractors Submitting An Offer In The Procedure Declare That They Undertake To Comply With The Following Requirements: 1) They Will Offer Medicinal Products That Meet The Requirements Specified In The Act Of September 6, 2001. Pharmaceutical Law (Journal Of Laws 2026.612, I.E. Of 2026/05/07), In Accordance With The Description Of The Subject Of The Order Contained In The Assortment And Price Forms Constituting Annex No. 3 To The Swz.2) The Contractor Has Documents Confirming That The Products Listed In The Assortment And Price Forms Constituting Annex No. 3 To The Swz Are Registered In The Office For Registration Of Medicinal Products, Medical Devices And Biocidal Products In Accordance With The Requirements Of The Act Of September 6, 2001. Pharmaceutical Law (Journal Of Laws 2026.612, I.E. Of 2026/05/07).3) For Drugs In All Packages 1-5, The Ordering Party Requires A Valid Gif Permit To Trade In Medicinal Products.4) Packages 1-2 Include Biological Drugs For Drug Programs. The Ordering Party Requires That The Drugs Are Approved For Use And Reimbursed In Drug Programs. Currently, They Are To:03.0000.331.02 (B31) Treatment Of Pulmonary Arterial Hypertension03.0000.461.02 (B161) Treatment Of Patients With Purulent Inflammation Of Apocrine Sweat Glands. The Ordering Party Also Requires That: A) The Entire Range Consists Of Medicinal Products. B) The Contractor Will Sign Annexes To The Contracts If The Reimbursement During The Period Of The Contract Is Changed To Products (With The Same International Name). Which Will Be Covered By Such A Refund. C) The Price Of The Drug In The Case Of A Drug Covered By The Official Price During The Entire Duration Of The Contract Must Be Consistent With The Current Official Price Of The Given Drug On The Day Of The Order Execution, In The Event Of A Change In The Principles Of Financing The Purchase Of Drugs By The National Health Fund, Lowering Prices Or Lowering The Official Price Of The Drug Below The Price Resulting From The Offer, The Contractors Will Sign An Annex For The Duration Of Their Validity, After This Period The Price Will Return To The Price Resulting From The Contractors Original Tender Offer, Which Is Always The Price For The Ordering Party Maximum.D) The Product Will Be Transported To The Place Indicated By The Ordering Party In Accordance With The Requirements Set Out In The Chpl For Medicinal Products.E) The Contractor Will Provide The Summary Of Product Characteristics (Spc) Or Its Equivalent Translation Into Polish (Packages 1-2) With The Offer. 5) The Contractor Will Ensure, At Its Own Expense And Risk, The Transport Of Medicinal Products To The Place Indicated By The Ordering Party. The Transport Of All Medicinal Products Will Be Carried Out In Accordance With The Requirements Provided For In The Curren
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
07aade8b-aec2-489f-b208-04aabb5c481e.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.